Grand Pharmaceutical Says CBT-001 Phase III Trial Meets Primary Endpoint
Grand Pharmaceutical said its CBT-001 Phase III trial reached its primary clinical endpoint.
Grand Pharmaceutical said its CBT-001 Phase III trial reached its primary clinical endpoint.